A recap of Lilly's triple-hormone shot, including the 28.3% average loss at 12 mg in TRIUMPH-1 and a head-to-head with tirzepatide due around November 2026.
Recap by typeshit. Full story at WorldHealth.net.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A Mayo Clinic Florida study of over 3,800 women found 9.8% vs 8.2% weight loss at 9 months with HT on semaglutide. Researchers say it shows association, not cause.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
His GLP-1 series turns to heart failure with preserved ejection fraction, where the heart pumps normally but struggles to relax and fill.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
Loading…